The Triple-A-COAT project aims to develop a bio-based antiviral/antimicrobial/antifungal coating platform for high traffic surfaces and textiles.
Horizon Europe – European Union
2.-0 LCA consultants are part of a diverse project consortium involving 13 companies, academic and SME partners each with leading expertise. We take care of the LCA aspects of the project.
Improving antimicrobial coating efficacy and sustainability with nanocellulose
In Triple-A-COAT* three forms of nanocellulose will be augmented for antimicrobial/antiviral/antifungal activity through grafting/adsorption of novel, resistance-proof compounds with excellent activities against bacteria, fungi and/or viruses, and nanopatterning to create bio-inspired antimicrobial surfaces.
Nanocellulose is a versatile nanomaterial obtained from wood pulp or biotechnological methods. It has excellent physical properties for coatings, enabling controllable and standardised application of antimicrobial functionalities.
The goal of the project is to meet or exceed current antimicrobial/antiviral/antifungal coatings efficacy, but with a minimal risk of resistance development and avoiding the safety issues of inorganic nanoparticles. In Triple-A-COAT, 2.-0 LCA consultants will apply LCA to the production, use and disposal of nanocellulose, and compare the LCAs of the best performing coatings with competing products. This may identify ways in which Triple-A-COAT partners can optimize the sustainability of the coatings even further.
Within 5-10 years after the end of the project, the results will be commercialized for impact in the transportation and healthcare sectors, contributing to the better control of infectious disease, and boosting the competitiveness and research leadership of EU industry including SMEs.